Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-high Risk”

761 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 761 results

Not applicableUnknownNCT05706467
What this trial is testing

The Difference Between Non-invasive High-frequency Oscillatory Ventilation and Non-invasive Continuous Airway Pressure Ventilation in COVID-19 With Acute Hypoxemia

Who this might be right for
COVID-19 PneumoniaNon-invasive Ventilation
Guangzhou Institute of Respiratory Disease 20
Not applicableUnknownNCT05532111
What this trial is testing

Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial

Who this might be right for
Efficacy and Safety
RenJi Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT06991868
What this trial is testing

Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

Who this might be right for
NMIBCMIBCUTUC
Peking University First Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT00003113
What this trial is testing

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 6
Large-scale testing (Phase 3)Not Yet RecruitingNCT07239674
What this trial is testing

Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

Who this might be right for
Intermediate-to-High Risk Differentiated Thyroid Cancer
West China Hospital 646
Early research (Phase 1)Study completedNCT06801418
What this trial is testing

Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

Who this might be right for
Healthy Volunteers
Mirati Therapeutics Inc. 160
Not applicableStudy completedNCT03560505
What this trial is testing

High-resolution Ultrasound in Lower Extremity Nerves and Common Fibular Neuropathies.

Who this might be right for
UltrasonographyPeroneal Neuropathies
Sándor Beniczky 90
Testing effectiveness (Phase 2)Study completedNCT01314014
What this trial is testing

Imexon for Relapsed Follicular and Aggressive Lymphomas

Who this might be right for
Follicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more
University of Rochester 22
Not applicableStudy completedNCT01542021
What this trial is testing

Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer

Who this might be right for
Prostate CancerProstatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT02935361
What this trial is testing

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
University of Southern California 33
Testing effectiveness (Phase 2)UnknownNCT03145961
What this trial is testing

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 208
Testing effectiveness (Phase 2)Ended earlyNCT03946670
What this trial is testing

MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 127
Post-approval studies (Phase 4)Active Not RecruitingNCT06627530
What this trial is testing

COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

Who this might be right for
Prostate Cancer
Brazilian Clinical Research Institute 144
Large-scale testing (Phase 3)UnknownNCT00175396
What this trial is testing

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Who this might be right for
Prostate Cancer
University of British Columbia 400
Not applicableStudy completedNCT05286866
What this trial is testing

Comparison Between High-speed Drilling With Irrigation and Low-speed Drilling With Irrigation

Who this might be right for
Bone Loss
University of Valencia 50
Not applicableUnknownNCT01916512
What this trial is testing

Relationship Between CETP Deficiency and Atherosclerosis in Patients With Hyperalphalipoproteinemia

Who this might be right for
Low CETP ActivityCETP DeficiencyHyperalphalipoproteinemia+2 more
Osaka University 1,500
Not applicableStudy completedNCT07345234
What this trial is testing

Comparison Between Supine Mini-PCNL and Flexible Ureteroscopy (FURS) for Dense Lower Calyceal Stones (1-2 cm) in School-Age Pediatric Patients

Who this might be right for
NephrolithiasisKidney CalculiUrolithiasis
Ain Shams University 180
Not applicableStudy completedNCT03859492
What this trial is testing

Screening CEDM in Intermediate and High-Risk Patient Populations

Who this might be right for
Breast Cancer
Mayo Clinic 461
Not applicableLooking for participantsNCT03417336
What this trial is testing

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk

Who this might be right for
To Evaluate the Rate of Digestive and Urinary Toxicity
Centre Georges Francois Leclerc 90
Next Page